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Available online 6 January 2016Human embryonic stem cell line BJNhem20-TetR was generated using non-viral method. The construct
pCAG-TetRnls was transfected using microporation procedure. BJNhem20-TetR can subsequently be transfected
with any vector harbouring a TetO (Tet operator) sequence to generate doxycycline based inducible line. For
example, in human embryonic stem cells, the pSuperior based TetO system has been transfected into a TetR
containing line to generate OCT4 knockdown cell line (Zafarana et al., 2009). Thus BJNhem20-TetR can be used
as a tool to perturb gene expression in human embryonic stem cells.
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To generate BJNhem20-TetR cell line, we transfected BJNhem20
by microporation at 1100 V, 30 ms pulse width and 1 pulse number.
A stable hESC line was generated after subjecting these transfected
cells to puromycin selection for two weeks. Expression of pluripotent. This is an open access article understem cell markers OCT4, SSEA3, TRA1-60 and TRA1-81 has been
shown by immunostaining. Differentiation of BJNhem20-TetR to
all the three germ layers was demonstrated by immunostaining
for beta III tubulin (ectodermal), Brachyury (mesodermal) and AFP
(endodermal). Karyotype was also checked in these cells and found
to be normal.Materials and methods
Cell culture
hESC line BJNhem20was derived from discarded Grade III embry-
os and tested for pluripotency (Inamdar et al., 2009). This cell line
has been cultured continuously for over 200 passages without
acquiring any karyotypic abnormality (Venu et al., 2010). The cell
line was included in the analysis of genetic stability in the International
Stem Cell Initiative project (ISCI2, 2011). Cultures of BJNhem20 and
the transgenic line BJNhem20-TetR were maintained on mouse
embryonic fibroblast feeder layers in hESC medium composed
of KnockOut Dulbecco's modified Eagle medium (KO-DMEM-Life
Technologies; Cat no. 10829-018) supplemented with 20% KnockOut
Serum replacement (KOSR-Life Technologies; Cat no. 10828-028),
1% GlutaMAX (Life Technologies; Cat no. 35050-061), 1% non-
essential amino acids (MEM-NEAA-Life Technologies; Cat no.
11140-050), 0.1% β-mercaptoethanol (Life Technologies; Cat no.
21985-023) and 8 ng/ml human recombinant basic fibroblast growth
factor (human bFGF-Sigma Aldrich Pvt. Ltd.; Cat no. F-0291). These
cells were routinely passaged by mechanical cutting of undifferenti-
ated colonies. The plasmid pCAG TetRnls was a kind gift from Peter
Andrews (University of Sheffield, UK).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Expression and karyotype analysis of BJNhem20-TetR line. A) Validation of BJNhem20-TetR cell line grown on matrigel by immunostaining with TetR antibody. B) Pluripotency
marker expression in BJNhem20-TetR by immunostaining for OCT4, SSEA3, TRA 1-60 and TRA 1-81. C) Analysis of transcript levels of pluripotency marker genes by reverse
transcription and polymerase chain reaction (RT-PCR) amplification. D) Differentiation analysis of BJNhem20-TetR: Embryoid bodies stained to show differentiation to all the three
germ layers by immunostaining (red) for AFP, Brachyury and β III-Tubulin marking the endoderm, mesoderm and ectoderm respectively. E) Karyotype analysis of BJNhem20-TetR.
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For microporation, BJNhem20 cells were grown onMatrigel (Becton
Dickinson; Cat no. 354277) coated dishes till they were 60–70%
confluent. The cellswere trypsinizedwith 1X TrypLE (Life Technologies;
Cat no. 12605-010) at 37 °C for 4 min. The cells were pelleted by
centrifugation at 1000 rpm for 2 min and washed with phosphate
buffered saline and enumerated. 0.5 million cells were resuspendedin 10 μl of R buffer and 6 μg of DNA was mixed and the cells were
transfected in amicroporator (NeonMicroporation Kit-Life Technologies;
Cat no. MPK1096). Microporation conditions used were 1100 V, 30 ms
and 1 pulse according to the manufacturer's instructions. The cells
were then directly seeded onto Matrigel-coated dishes with mTESR
media (Stem Cell Technologies; Cat no. 05850) supplemented
with ROCK inhibitor (10 μM Y-27632, Sigma Aldrich Pvt. Ltd.;
Cat no. Y0503) to aid the survival of single cells. mTESR medium
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adhered. 48 h after transfection, puromycin (0.5 μg/ml Sigma Aldrich
Pvt. Ltd.; Cat no. P8833) was added to the transfected culture and
selection was continued for 10 days. Puromycin resistant individual
clones were manually picked and passaged. BJNhem20-TetR cells
were subsequently cultured in both feeder free conditions on
matrigel in the presence of mTESR medium and on feeders with
regular hESC medium.
Embryoid body differentiation
Differentiation of embryoid bodies was carried out as described
before (Inamdar et al., 2009). Briefly, colonies grown on MEFs were
mechanically cut and pieces cultured in human embryoid body media
(10% FBS-Hyclone; Cat no. SH30070 with β-mercaptoethanol and
GlutaMAX in DMEM) on low attachment plates. These hESC aggregates
were allowed to grow in suspension for 3 days after which the colonies
formed embryoid body-like structures and were transferred to the
tissue culture dishes pre-treatedwith 0.1% gelatin and allowed to attach
and differentiate spontaneously till the time for harvest from day 6
onwards for immunostaining analyses.
Immunostaining
hESC and hEBs were fixed in 2% paraformaldehyde (in PBS),
permeabilized with Triton-X 100 (0.1% for cells and 0.3% for EBs)
and then blocked with 4% FBS for 1 h at RT (Room Temperature).
Post blocking, cells were incubated with the appropriate primary
antibodies overnight at 4 °C, then were washed with PBS at RT and
incubated with secondary antibody conjugated to either Alexa
Fluor 488 or 568 for 1 h at RT (Dilution 1:400 Invitrogen). The cells
were washed and stained using DAPI (1:500 in M1 buffer Invitrogen)
to visualize nuclei. The images were acquired using an epifluorescence
microscope (IX-81 microscope system (Olympus)) fitted with a cooled
CCD camera (CoolSnap, Roper Scientific). Primary antibodies used
were against TetR (Clonetech; Clone 9G9 Cat no. 631131), Oct4 (BD
Biosciences BD611203), TRA1-81 and SSEA3 monoclonal antibodies
were a kind gift from Peter Andrews (University of Sheffield, UK),
Brachyury (Santa Cruz Biotech; Cat no. SC-17743), β-III tubulin, AFP
(Sigma Chemical Pvt. Ltd.; Cat no. A8452).
RNA isolation/cDNA synthesis and PCR
Total RNAwas extracted fromcells by TRIzol reagent (Life Technologies;
Catno. 15596-026) following themanufacturer's instructions. 2 μgofDNasetreated RNA was converted to cDNA by performing reverse transcription
using Superscript II (Life Technologies; Cat no. 18064-014). Primer
sequences used for cDNA amplification (5′–3′) were as follows:Primer name SequenceCT4_F GAAGGTATTCAGCCAAACGAC
CT4_R GTTACAGAACCACACTCGGA
X2_F AGTCTCCAAGCGACGAAAAA
X2_R GCAAGAAGCCTCTCCTTGAA
APDH_F GTCCATGCCATCACTGCCA
APDH_R TTACTCCTTGGAGCCATG
T_F GGTTGCGTATTGGAAGAT
T_R TTCAAGGCCGAATAAGAATEVerification of karyotype
Standard G banding of metaphase spreads was performed and
analysed using CytoVision software. For each sample, at least
50 metaphases were counted and 10 were analysed.Acknowledgements
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